Uncategorized
Avedro, EyeGate Pharma to enter agreement
EyeGate Pharma’s broad iontophoresis patent portfolio for corneal collagen cross-linking
will be held as exclusive license by Avedro Inc. Delivery approach provides potential additional benefits to
current formulation.